Related Experiment Video
Updated: Aug 17, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Angiotensin type-2 receptors and cardiovascular function: are angiotensin type-2 receptors protective?
1Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22908, USA. mc4c@virginia.edu
Purpose Of Review:
The renin-angiotensin system is a coordinated hormonal cascade of critical importance to the regulation of blood pressure and cardiovascular function. The major effector peptide, angiotensin II, binds to two major receptors, angiotensin type-1 and angiotensin type-2. Most of the actions of angiotensin II are mediated by the angiotensin type-1 receptor, but recent evidence strongly suggests that the angiotensin type-2 receptor opposes the angiotensin type-1 receptor, particularly by promoting vasodilatation instead of vasoconstriction.
Recent Findings:
Conclusive evidence has been presented indicating that the angiotensin type-2 receptor mediates vasodilatation in small resistance arterioles as well as in the coronary microcirculation. Substantial evidence also is available that the angiotensin type-2 receptor dilates large capacitance vessels, including the aorta, subjected to pressure-overload. The angiotensin type-2 receptor has recently been found to inhibit renin biosynthesis and secretion similar to the action of the angiotensin type-1 receptor. The angiotensin type-2 receptor appears to be cardioprotective, particularly in limiting cardiac remodeling following ischemic injury.
Summary:
The angiotensin type-2 receptor represents an important area of cardiovascular investigation with potential therapeutic implications for cardiac disease and hypertension.
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Action of β1 Blockers
Hypertension II: Pathophysiology
